Toyobo Co., Ltd. TSE:3101

Toyobo : Consolidated Financial Report for the Six Months Ended September 30, 2024

Published

Source: MarketScreener

November 7, 2024

Consolidated Financial Report for the Six Months Ended September 30, 2024

TOYOBO Co., Ltd.

URL

https://ir.toyobo.co.jp/en/ir.html

Stock Code: 3101 (Prime Market, Tokyo Stock Exchange)

Representative: Ikuo Takeuchi, President and Representative Director

Contact Person: Sonoko Ishimaru, Executive Officer, General Manager, Corporate Communication Department

TEL: +81-6-6348-3044

Planned Filing Date of a Semi-annual Securities Report: November 14, 2024

(Figures are rounded to the nearest million yen)

1. Consolidated Business Performance

  1. Consolidated Operating Results

Six months ended September 30

Percentages indicate year-on-year increase/ (decrease)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

2024

209,161

4.9

6,931

193.5

3,180

206.5

114

(94.3)

2023

199,419

(0.8)

2,361

(70.1)

1,038

(84.7)

2,011

(81.7)

(Note) Comprehensive Income:

Six months ended September 30, 2024: ¥2,018 million (51.4%)

Six months ended September 30, 2023: ¥4,150 million (69.2%)

Net profit per

Net profit per share

share

after dilution

Yen

Yen

2024

1.29

2023

22.82

  1. Consolidated Financial Position

Total assets

Net assets

Equity ratio

Net assets per share

Millions of yen

Millions of yen

%

Yen

September 30,

603,176

228,869

32.0

2,191.14

2024

March 31,

606,990

230,087

32.5

2,236.50

2024

(Reference) Total shareholders' equity: September 30, 2024: ¥193,200 million, March 31, 2024: ¥197,033 million

2. Dividends

Years ended/ending March 31

Dividends per share

Record date

1st Quarter

2nd Quarter

3rd Quarter

Year-end

Total

Yen

Yen

Yen

Yen

Yen

2024

0.00

40.00

40.00

2025

0.00

2025

40.00

40.00

(Forecast)

(Note) Revision of dividends forecast for this period: None

1

3. Forecasts for Fiscal Year Ending March 31, 2025

Percentages indicate year-on-year increase/ (decrease)

Net sales

Operating profit

Ordinary profit

Millions of yen

%

Millions of yen

%

Millions of yen

%

Fiscal year

435,000

5.0

17,000

89.0

11,500

65.2

Profit attributable to

Net profit per share

owners of parent

Millions of yen

%

Yen

Fiscal year

2,600

5.9

29.50

(Note) Revision of earnings forecast for this period: None

4. Other

1. Significant changes in the scope of consolidation during the subject fiscal year: None

1) New company

: None

    1. Excluded company : None
  1. Adoption of simplified and special accounting methods: None
  2. Changes from accounting methods, procedures and the presentation of the consolidated financial statements:

1) Changes based on revision of accounting standards

: None

2) Changes other than 1) above

: None

3) Changes due to accounting estimation change

: None

4) Error correction

: None

4. Number of shares issued and outstanding (common stock):

  1. Number of shares outstanding (including treasury stock):

September 30, 2024:

89,048,792 shares

March 31, 2024:

89,048,792 shares

2) Number of treasury stock:

September 30, 2024:

875,462 shares

March 31, 2024:

949,992 shares

    1. Average number of shares outstanding for each period (cumulative term): Six months ended September 30, 2024: 88,129,699 shares
      Six months ended September 30, 2023: 88,094,277 shares
  • Semi-annualfinancial results reports are exempt from review conducted by certified public accountants or an audit firm.
  • Explanation regarding the appropriate use of forecasts of business results

The forward-looking statements made in this document, including the aforementioned forecasts, are based on all information available to the management at the time of this document's release. Actual results may differ from the results anticipated in the statements.

(How to obtain supplementary document on earnings)

The supplementary document on earnings is disclosed on the same day as the Semi-annual financial results report, and it is made available on the Company's website.

2

1. Qualitative Information and Financial Statements

(1) Qualitative Information on Consolidated Results

In the business environment surrounding the Toyobo Group (hereinafter "the Group") in the six months ended September 30, 2024, in the United States, steady economic activity was supported by consumer spending amid a change to lowering the policy interest rate as price inflation slowed. In China, the economy remained weak due to a downturn in internal demand with factors including a prolonged real estate recession and weak consumption. In Japan, the economy has recovered moderately due to increased inbound tourism demand and expansion of capital investment amid a hike in the policy interest rate. Looking ahead, the business environment is expected to be impacted by raw material and fuel price fluctuations due to the destabilization of the international situation and by economic trends in China, the United States, and others.

Under this business environment, a full-fledged recovery in demand for mold releasing film for multilayer ceramic capacitors (MLCC) and packaging film failed to materialize despite the moderate recovery in cargo movement. On the other hand, polarizer protective films for LCDs "COSMOSHINE SRF" and volatile organic compound (VOC) recovery equipment used in the manufacturing process for lithium-ion battery separators and traditional Arabic fabric remained steady.

As a result, consolidated net sales in the six months ended September 30, 2024 increased ¥9.7 billion (4.9%) over the same period of the previous fiscal year, to ¥209.2 billion. Operating profit increased ¥4.6 billion (193.5%), to ¥6.9 billion and ordinary profit increased ¥2.1 billion (206.5%) to ¥3.2 billion. Profit attributable to owners of parent decreased ¥1.9 billion (94.3%), to ¥0.1 billion.

Results by business segment were as follows:

Films

In the packaging film business, there was a moderate recovery in cargo movement, and the Company made progress on product price revisions for raw material and fuel prices; however, higher costs, mainly for new product development expenses, had an impact.

In the industrial film business, sales of mold releasing film for MLCC were sluggish as a full-fledged growth in demand failed to materialize despite the end of inventory adjustments throughout the supply chain. Sales of polarizer protective films for LCDs "COSMOSHINE SRF" were steady.

As a result, sales in this segment increased ¥4.8 billion (6.1%) from the same period of the previous fiscal year to ¥82.8 billion, and operating profit increased ¥1.6 billion (110.4%) to ¥3.0 billion.

Life Science

In the biotechnology business, sales of enzymes for diagnostic reagents were strong both in Japan and overseas, but expenses associated with the expansion of production capacity increased.

In the medical materials business, demand for artificial kidney hollow fiber trended strong, but an increase in expenses to launch a new plant, in addition to increased manufacturing costs, had an impact.

3

In the contract manufacturing business of pharmaceuticals, profitability improved as a result of the lifting of the Warning Letter by the FDA.

As a result, sales in this segment increased ¥0.6 billion (3.9%) from the same period of the previous fiscal year to ¥17.2 billion, and operating profit decreased ¥1.5 billion (62.2%) to ¥0.9 billion.

Environmental and Functional Materials

In the resin and chemical business, sales of engineering plastics increased for automotive use for the North and Central America. Sales of photo functional materials for water-wash photosensitive printing plates increased, mainly in China.

In the environment and fiber business, environmental solutions sales of VOC recovery equipment and replacement elements used in the manufacturing process for lithium-ion battery separators increased. In addition, sales of brine concentration membrane equipment for lithium recovery contributed. In high performance fibers, overseas demand was steadily captured to achieve strong performance.

As a result, sales in this segment increased ¥2.7 billion (5.1%) from the same period of the previous fiscal year to ¥55.2 billion, and operating profit increased ¥3.0 billion (806.9%) to ¥3.4 billion.

Functional Textiles and Trading

In the textile business, sales of traditional Arabic fabric grew due to strong demand, and exports saw an uptick in profitability due to the effect of exchange fluctuations. In addition, profitability improved as a result of reforms of business structure such as the consolidation of production bases in Japan.

In the airbag fabric business, profitability improved as product price revisions proceeded.

As a result, sales in this segment increased ¥2.3 billion (5.0%) from the same period of the previous fiscal year to ¥47.9 billion, and operating profit of ¥0.1 billion (compared with operating loss of ¥0.9 billion for the same period of the previous fiscal year).

Real Estate and Other Business

This segment includes infrastructure-related businesses such as real estate, engineering, information processing services, and logistics services. Results in these businesses were generally in line with plans.

As a result, sales in this segment decreased ¥0.6 billion (9.7%) from the same period of the previous fiscal year to ¥6.0 billion, and operating profit decreased ¥0.2 billion (15.9%) to ¥1.2 billion.

(2) Analysis of Financial Position

Assets, Liabilities and Net Assets

Total assets decreased ¥3.8 billion (0.6%) from the end of the previous fiscal year, to ¥603.2 billion. This was mainly due to a decrease in cash and deposits, notes and accounts receivable - trade, despite an increase in property, plant and equipment due to capital investment.

4

Total liabilities decreased ¥2.6 billion (0.7%) to ¥374.3 billion. This was mainly due to a decrease in notes and accounts payable - trade, electronically recorded obligations - operating, despite an increase in borrowings.

Net assets decreased ¥1.2 billion (0.5%) from the end of the previous fiscal year, to ¥228.9 billion due to a decrease in retained earnings because of dividends paid and other factors, despite an increase in non-controlling interests.

Cash Flows

Net cash provided by operating activities amounted to ¥17.1 billion in the subject first half period. This was mainly due to depreciation of ¥11.2 billion and a cash increase of ¥2.9 billion due to a decrease in trade receivables, as well as profit before income taxes of ¥2.3 billion.

Net cash used in investing activities amounted to ¥24.3 billion. This was mainly due to purchase of property, plant and equipment and intangible assets of ¥24.6 billion.

Net cash provided by financing activities amounted to ¥1.3 billion. This was mainly due to proceeds from long-term borrowings of ¥30.6 billion and proceeds from issuance of bonds of ¥17.0 billion, and net decrease in short-term borrowings of ¥19.8 billion, redemption of bonds of ¥15.0 billion, repayments of long-term borrowings of ¥5.3 billion and dividends paid of ¥3.5 billion.

As a result, the balance of cash and cash equivalents at the end of the subject first half (September 30, 2024) stood at ¥27.1 billion, a decrease of ¥6.2 billion from the end of the previous fiscal year (March 31, 2024).

(3) Forecast for Fiscal 2025 (Ending March 31, 2025)

The performance of the Group in the six months ended September 30, 2024 was generally as forecast. Regarding the consolidated earnings forecast for fiscal year ending March 31, 2025, no changes have been made in the outlook announced on May 13, 2024.

5

2. Consolidated Financial Statements

(1) Consolidated Balance Sheets

(Millions of yen)

Previous Fiscal Year

Current First Half

(As of March 31, 2024)

(As of September 30, 2024)

Assets

Current assets

Cash and deposits

33,796

28,353

Notes and accounts receivable - trade

87,743

82,498

Contract assets

140

1

Electronically recorded monetary claims -

14,921

13,827

operating

Merchandise and finished goods

69,996

65,640

Work in process

20,566

21,656

Raw materials and supplies

31,421

32,674

Other

15,488

12,990

Allowance for doubtful accounts

(337)

(340)

Total current assets

273,733

257,300

Non-current assets

Property, plant and equipment

Buildings and structures, net

64,575

72,791

Machinery, equipment and vehicles, net

59,855

66,107

Land

91,049

90,396

Construction in progress

53,025

49,508

Other, net

12,972

13,112

Total property, plant and equipment

281,475

291,913

Intangible assets

4,670

4,857

Investments and other assets

Other

48,380

49,174

Allowance for doubtful accounts

(1,268)

(68)

Total investments and other assets

47,112

49,107

Total non-current assets

333,257

345,877

Total assets

606,990

603,176

6

(Millions of yen)

Previous Fiscal Year

Current First Half

(As of March 31, 2024)

(As of September 30, 2024)

Liabilities

Current liabilities

Notes and accounts payable - trade

49,782

44,721

Electronically recorded obligations - operating

4,229

3,135

Short-term borrowings

68,385

48,436

Current portion of bonds payable

15,000

10,000

Current portion of long-term borrowings

13,069

15,908

Provisions

5,308

5,526

Other

28,375

26,236

Total current liabilities

184,148

153,963

Non-current liabilities

Bonds payable

60,000

67,000

Long-term borrowings

85,637

108,192

Deferred tax liabilities for land revaluation

18,762

18,754

Provision for retirement benefits for directors

274

177

(and other officers)

Provision for environmental measures

11

11

Retirement benefit liability

15,901

15,322

Other

12,171

10,888

Total non-current liabilities

192,755

220,344

Total liabilities

376,903

374,307

Net assets

Shareholders' equity

Share capital

51,730

51,730

Capital surplus

33,187

32,647

Retained earnings

70,315

66,954

Treasury shares

(1,006)

(925)

Total shareholders' equity

154,227

150,406

Accumulated other comprehensive income

Valuation difference on available-for-sale

1,801

1,988

securities

Deferred gains or losses on hedges

(1)

(74)

Revaluation reserve for land

40,603

40,590

Foreign currency translation adjustment

(548)

(785)

Remeasurements of defined benefit plans

951

1,076

Total accumulated other comprehensive

42,806

42,794

income

Non-controlling interests

33,054

35,669

Total net assets

230,087

228,869

Total liabilities and net assets

606,990

603,176

7

  1. Consolidated Statements of Income and Consolidated Statements of Comprehensive Income

(Millions of yen)

(Consolidated Statements of Income)

Previous First Half

Current First Half

(From April 1, 2023

(From April 1, 2024

To September 30, 2023)

To September 30, 2024)

Net sales

199,419

209,161

Cost of sales

157,659

161,892

Gross profit

41,760

47,269

Selling, general and administrative expenses

39,399

40,338

Operating profit

2,361

6,931

Non-operating income

Foreign exchange gains

1,395

Compensation income

480

Other

898

1,210

Total non-operating income

2,293

1,690

Non-operating expenses

Interest expenses

636

917

Other

2,980

4,524

Total non-operating expenses

3,616

5,441

Ordinary profit

1,038

3,180

Extraordinary income

Gain on sale of shares of subsidiaries and

1,489

associates

Gain on sale of investment securities

3,047

78

Total extraordinary income

3,047

1,567

Extraordinary losses

Impairment losses

950

Loss on disposal of non-current assets

787

1,357

Loss on sale of non-current assets

125

Loss on change in equity

212

Total extraordinary losses

998

2,433

Profit before income taxes

3,086

2,314

Income taxes

1,519

165

Profit

1,567

2,149

Profit (loss) attributable to non-controlling interests

(444)

2,035

Profit attributable to owners of parent

2,011

114

8

(Millions of yen)

(Consolidated Statements of

Previous First Half

Current First Half

(From April 1, 2023

(From April 1, 2024

Comprehensive Income)

To September 30, 2023)

To September 30, 2024)

Profit

1,567

2,149

Other comprehensive income

Valuation difference on available-for-sale

(1,878)

183

securities

Deferred gains or losses on hedges

96

(116)

Foreign currency translation adjustment

3,647

(1,008)

Remeasurements of defined benefit plans, net of

267

125

tax

Share of other comprehensive income of entities

451

684

accounted for using equity method

Total other comprehensive income

2,584

(131)

Comprehensive income

4,150

2,018

Comprehensive income attributable to

Comprehensive income attributable to owners of

4,170

162

parent

Comprehensive income attributable to

(20)

1,856

non-controlling interests

9

(3) Consolidated Statements of Cash Flows

(Millions of yen)

Previous First Half

Current First Half

(From April 1, 2023

(From April 1, 2024

To September 30, 2023)

To September 30, 2024)

Cash flows from operating activities

Profit before income taxes

3,086

2,314

Depreciation

9,395

11,178

Interest expenses

636

917

Decrease (increase) in trade receivables

5,005

2,912

Decrease (increase) in inventories

(3,924)

(259)

Increase (decrease) in trade payables

(5,568)

(3,020)

Other, net

3,105

6,113

Subtotal

11,736

20,156

Income taxes refund (paid)

(1,655)

(3,056)

Net cash provided by (used in) operating activities

10,081

17,100

Cash flows from investing activities

Purchase of property, plant and equipment and

(28,772)

(24,585)

intangible assets

Other, net

1,839

246

Net cash provided by (used in) investing activities

(26,933)

(24,339)

Cash flows from financing activities

Net increase (decrease) in short-term borrowings

(22,022)

(19,790)

Proceeds from long-term borrowings

30,208

30,600

Repayments of long-term borrowings

(8,554)

(5,307)

Proceeds from issuance of bonds

17,000

Redemption of bonds

(10,000)

(15,000)

Interest paid

(628)

(864)

Dividends paid

(3,527)

(3,519)

Other, net

(900)

(1,844)

Net cash provided by (used in) financing activities

(15,423)

1,277

Effect of exchange rate change on cash and cash

1,510

(261)

equivalents

Net increase (decrease) in cash and cash

(30,765)

(6,223)

equivalents

Cash and cash equivalents at beginning of period

60,204

33,310

Cash and cash equivalents at end of period

29,439

27,087

10